A National Quality Improvement Collaborative to Improve Antibiotic Use in Pediatric Infections

Author:

McCulloh Russell J.12,Kerns Ellen13,Flores Ricky3,Cane Rachel4,El Feghaly Rana E.56,Marin Jennifer R.7,Markham Jessica L.86,Newland Jason G.9,Wang Marie E.10,Garber Matthew11

Affiliation:

1. aDepartment of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska

2. bDivisions of Pediatric Hospital Medicine

3. cCare Transformation, Children’s Nebraska, Omaha, Nebraska

4. dDepartment of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland

5. eDivisions of Infectious Diseases

6. gDepartment of Pediatrics, University of Missouri Kansas City, Kansas City, Missouri

7. hDivision of Pediatric Emergency Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

8. fPediatric Hospital Medicine, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri

9. iDepartment of Pediatrics, Washington University School of Medicine, Division of Pediatric Infectious Diseases, St Louis, Missouri

10. jDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, California

11. kDepartment of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida

Abstract

BACKGROUND Nearly 25% of antibiotics prescribed to children are inappropriate or unnecessary, subjecting patients to avoidable adverse medication effects and cost. METHODS We conducted a quality improvement initiative across 118 hospitals participating in the American Academy of Pediatrics Value in Inpatient Pediatrics Network 2020 to 2022. We aimed to increase the proportion of children receiving appropriate: (1) empirical, (2) definitive, and (3) duration of antibiotic therapy for community-acquired pneumonia, skin and soft tissue infections, and urinary tract infections to ≥85% by Jan 1, 2022. Sites reviewed encounters of children >60 days old evaluated in the emergency department or hospital. Interventions included monthly audit with feedback, educational webinars, peer coaching, order sets, and a mobile app containing site-specific, antibiogram-based treatment recommendations. Sites submitted 18 months of baseline, 2-months washout, and 10 months intervention data. We performed interrupted time series (analyses for each measure. RESULTS Sites reviewed 43 916 encounters (30 799 preintervention, 13 117 post). Overall median [interquartile range] adherence to empirical, definitive, and duration of antibiotic therapy was 67% [65% to 70%]; 74% [72% to 75%] and 61% [58% to 65%], respectively at baseline and was 72% [71% to 72%]; 79% [79% to 80%] and 71% [69% to 73%], respectively, during the intervention period. Interrupted time series revealed a 13% (95% confidence interval: 1% to 26%) intercept change at intervention for empirical therapy and a 1.1% (95% confidence interval: 0.4% to 1.9%) monthly increase in adherence per month for antibiotic duration above baseline rates. Balancing measures of care escalation and revisit or readmission did not increase. CONCLUSIONS This multisite collaborative increased appropriate antibiotic use for community-acquired pneumonia, skin and soft tissue infections, and urinary tract infection among diverse hospitals.

Publisher

American Academy of Pediatrics (AAP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3